Piperidine renin inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8580823
APP PUB NO 20120225906A1
SERIAL NO

13469562

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to aspartic protease inhibitors represented by the following structural formula:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VITAE PHARMACEUTICALS INC502 WEST OFFICE CENTER DRIVE FORT WASHINGTON PA 19034

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baldwin, John J Gwynedd Valley, US 214 2088
Cacatian, Salvacion Blue Bell, US 49 482
Claremon, David A Maple Glen, US 167 2136
Dillard, Lawrence W Yardley, US 55 1025
Flaherty, Patrick T Pittsburgh, US 20 53
Ishchenko, Alexey V Somerville, US 22 60
Jia, Lanqi Horsham, US 42 281
McGeehan, Gerard Garnet Valley, US 28 172
Simpson, Robert D Wilmington, US 34 299
Singh, Suresh B Kendall Park, US 95 1396
Tice, Colin M Ambler, US 98 1489
Xu, Zhenrong Horsham, US 57 628
Yuan, Jing Lansdale, US 135 622
Zhao, Wei Eagleville, US 814 5746

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 12, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00